- Home
- REPL vs EDN Comparison
REPL vs EDN Comparison
Compare REPL & EDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REPL
- EDN
- Stock Information
- Founded
- REPL 2015
- EDN 1992
- Country
- REPL United States
- EDN Argentina
- Employees
- REPL N/A
- EDN N/A
- Industry
- REPL Biotechnology: Pharmaceutical Preparations
- EDN Electric Utilities: Central
- Sector
- REPL Health Care
- EDN Utilities
- Exchange
- REPL Nasdaq
- EDN Nasdaq
- Market Cap
- REPL 690.7M
- EDN 849.6M
- IPO Year
- REPL 2018
- EDN 2007
- Fundamental
- Price
- REPL $10.37
- EDN $21.22
- Analyst Decision
- REPL Strong Buy
- EDN
- Analyst Count
- REPL 5
- EDN 0
- Target Price
- REPL $23.40
- EDN N/A
- AVG Volume (30 Days)
- REPL 516.2K
- EDN 65.6K
- Earning Date
- REPL 08-08-2024
- EDN 09-17-2024
- Dividend Yield
- REPL N/A
- EDN N/A
- EPS Growth
- REPL N/A
- EDN N/A
- EPS
- REPL N/A
- EDN 0.28
- Revenue
- REPL N/A
- EDN $880,068,817.00
- Revenue This Year
- REPL N/A
- EDN $138.93
- Revenue Next Year
- REPL $421.49
- EDN $165.83
- P/E Ratio
- REPL N/A
- EDN $5.12
- Revenue Growth
- REPL N/A
- EDN N/A
- 52 Week Low
- REPL $4.92
- EDN $10.06
- 52 Week High
- REPL $20.05
- EDN $21.80
- Technical
- Relative Strength Index (RSI)
- REPL 53.05
- EDN 72.85
- Support Level
- REPL $10.13
- EDN $17.36
- Resistance Level
- REPL $11.32
- EDN $19.77
- Average True Range (ATR)
- REPL 0.63
- EDN 0.91
- MACD
- REPL -0.00
- EDN 0.31
- Stochastic Oscillator
- REPL 35.91
- EDN 94.96
About REPL Replimune Group Inc.
Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3.
About EDN Empresa Distribuidora Y Comercializadora Norte S.A. (Edenor)
Empresa Distribuidora y Comercializadora Norte SA is engaged in the distribution and sale of electricity. The firm's concession area covers the northern portion of the city of Buenos Aires mainly to residential, commercial, industrial, and public service.